BBSRC Portfolio Analyser
Award details
Tissue selective drug delivery using tissue inhibitors of metalloproteinases as carriers
Reference
BCI06265
Principal Investigator / Supervisor
Professor Philip Blower
Co-Investigators /
Co-Supervisors
Professor Robert Freedman
,
Dr Richard Williamson
Institution
University of Kent
Department
University of Kent Department
Funding type
Research
Value (£)
76,873
Status
Completed
Type
Research Grant
Start date
01/10/1996
End date
01/10/1998
Duration
24 months
Abstract
Conjugates of deltaTIMP-2, an active domain of tissue inhibitor of metalloproteinase-2 will be synthesised and their tissue selectively assessed in vitro and in tumour bearing mice, with a view to design of tissue-selective cytotoxic and anti-inflammatory drug delivery agents and radiopharmaceuticals.
Summary
unavailable
Committee
Closed Committee - Biomolecular Sciences (BMS)
Research Topics
X – not assigned to a current Research Topic
Research Priority
X – Research Priority information not available
Research Initiative
Biological Chemistry Initiative (BCI) [1995]
Funding Scheme
X – not Funded via a specific Funding Scheme
I accept the
terms and conditions of use
(opens in new window)
export PDF file
back to list
new search